M. Cecilia Berin, PhD
- PROFESSOR | Pediatrics
Research Topics:
Allergy, Antigen Presentation, Cellular Immunity, Chemokines, Cytokines, Dendritic Cells, Epithelial Cells, Immunology, Inflammation, Knockout Mice, Mucosal Immunology, T CellsCecilia Berin is a Professor of Pediatrics and Deputy Director of the Jaffe Food Allergy Institute. Her laboratory studies immune mechanisms of allergy and tolerance to foods, and early life susceptibility to allergic disease.
Lab Website: http://labs.icahn.mssm.edu/berinlab/home
Multi-Disciplinary Training Area
Immunology [IMM]Education
BSc(Hons), Queen's University
MSc, Queen's University
PhD, McMaster University
Postdoctoral, University of California, San Diego
Our laboratory is dedicated to understanding the mucosal immunology of food allergic disorders. Themes within this work include (1) understanding mechanisms responsible for development of sensitization and tolerance to food proteins, (2) determining how allergen-specific T cells home to the gut and induce disease, and (3) finding methods to modify the allergen-specific T cell response for therapeutic purposes. Much of our lab’s work to date has focused on the communication between gastrointestinal epithelial cells, dendritic cells, and antigen-specific T cells in the context of food allergy.
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Dr. Berin did not report having any of the following types of financial relationships with industry during 2018 and/or 2019: consulting, scientific advisory board, industry-sponsored lectures, service on Board of Directors, participation on industry-sponsored committees, equity ownership valued at greater than 5% of a publicly traded company or any value in a privately held company. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.